Detection of high‐grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings

Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HP...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 147; no. 11; pp. 3068 - 3074
Main Authors Farnsworth, Annabelle, Roberts, Jennifer M., Garland, Suzanne M., Crescini, Joanne, Kaldor, John M., Machalek, Dorothy A.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0020-7136
1097-0215
1097-0215
DOI10.1002/ijc.33128

Cover

Abstract Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology (P‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted. What's new? Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age.
AbstractList Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted.Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted.
Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high-grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high-grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P-trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC-H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age-groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P-trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC-H cytology (P-trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P-trend = .211). This report describes the first follow-up colposcopy findings in Australia's new HPV-based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk-based algorithm to account for age may be warranted.
Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups (P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years (P‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology (P‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age (P‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted. What's new? Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age.
Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with colposcopy and, if indicated, biopsy. We reviewed results for 2300 women referred directly for colposcopy after their first positive HPV screening test, to determine the proportion that had underlying histological high‐grade abnormality (HGA). Overall, HGA was detected in 24.3% of women. Among HPV16/18 positive women, 18.0% had HGA, increasing from 6.6% among women with negative cytology to 79.7% among women with high‐grade squamous lesion or worse, or any glandular lesion on cytology (HSIL+; P ‐trend < .001). For this latter group, the proportion with HGA was higher among HPV16/18 positive women than among those positive for other oncogenic types (68.8%; P = .029). Among women with ASC‐H cytology, 51.8% had HGA, with no difference between HPV groups ( P = .314). In analyses by age‐groups, detection of HGA was highest, at 36.4%, among women younger than 35 years, then decreased significantly to 5.9%, among women aged 65 to 74 years ( P ‐trend < .001). The relationship of decreasing HGA detection with increasing age was strong for women with negative cytology, and those with ASC‐H cytology ( P ‐trend < .001 for each). For women with HSIL+ cytology, detection of HGA was high and stable, regardless of age ( P ‐trend = .211). This report describes the first follow‐up colposcopy findings in Australia's new HPV‐based cervical screening program. The results demonstrate the additional value of reflex cytology in managing HPV positive women and suggest that further refinement of the risk‐based algorithm to account for age may be warranted. What's new? Australia's new human papilloma virus (HPV)‐based cervical screening program relies on a risk‐based algorithm incorporating reflex cytology to guide decisions about follow‐up colposcopy. In this report of the first follow‐up colposcopy findings, nearly one in four women referred directly for colposcopy under the algorithm had an underlying histological high‐grade abnormality (HGA). Detection of HGA increased with increasing grade of reflex cytology, but there was a substantial reduction in HGA detection with increasing age. The results demonstrate the additional value of reflex cytology in managing HPV‐positive women and suggest that the risk‐based algorithm should be further refined to account for age.
Author Roberts, Jennifer M.
Crescini, Joanne
Machalek, Dorothy A.
Garland, Suzanne M.
Farnsworth, Annabelle
Kaldor, John M.
Author_xml – sequence: 1
  givenname: Annabelle
  orcidid: 0000-0002-2358-4972
  surname: Farnsworth
  fullname: Farnsworth, Annabelle
  email: afarnsworth@dhm.com.au
  organization: University of Notre Dame
– sequence: 2
  givenname: Jennifer M.
  surname: Roberts
  fullname: Roberts, Jennifer M.
  organization: Douglass Hanly Moir Pathology
– sequence: 3
  givenname: Suzanne M.
  surname: Garland
  fullname: Garland, Suzanne M.
  organization: Murdoch Children's Research Institute
– sequence: 4
  givenname: Joanne
  surname: Crescini
  fullname: Crescini, Joanne
  organization: Douglass Hanly Moir Pathology
– sequence: 5
  givenname: John M.
  surname: Kaldor
  fullname: Kaldor, John M.
  organization: University of New South Wales
– sequence: 6
  givenname: Dorothy A.
  surname: Machalek
  fullname: Machalek, Dorothy A.
  organization: University of Melbourne
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32484236$$D View this record in MEDLINE/PubMed
BookMark eNp9kUuOEzEQhi00iMkEFlwAWWIDi57xo92PJQqPGTQSLIBty22XO4667WA7iXrHETgCZ-MkOGRgMRKoFqVSff-vUv0X6Mx5Bwg9peSSEsKu7EZdck5Z8wAtKGnrgjAqztAi70hRU16do4sYN4RQKkj5CJ1zVjYl49UC_XgNCVSy3mFv8NoO65_fvg9BasAKwt4qOWJtI8gIWE7eDfjgJ3A4gIEQQOdlyPpxxslj5cetj8pvZyxNgoAlzrNNdg_4-uMXHFUAcDabJIgJ72WwEPHBpjWWQ_Z3Gqs5-dEPMzbW6UzGx-ihkWOEJ3d9iT6_ffNpdV3cfnh3s3p1WyhWNU1RadXwnhrRtqQuVWuIEQBa9YQSLUGLBrRpZKmENpxSRiTvlahJTSop6l7zJXpx8t0G_3WXz-smGxWMo3Tgd7FjJWkaxo-1RM_voRu_Cy5fl6myLZlgXGTq2R216yfQ3TbYSYa5-_P7DLw8ASr4GPND_yKUdMdcu5xr9zvXzF7dY5VN8hhbCtKO_1Mc7Ajzv627m_erk-IX0Ci3GA
CitedBy_id crossref_primary_10_3390_cancers13061224
crossref_primary_10_1159_000521911
crossref_primary_10_1111_aogs_14121
crossref_primary_10_1177_0969141321992404
crossref_primary_10_1002_ijc_34393
crossref_primary_10_1002_ijc_35185
crossref_primary_10_3389_fpubh_2022_950610
crossref_primary_10_3390_diagnostics12112585
crossref_primary_10_1002_jmv_29475
crossref_primary_10_1097_LGT_0000000000000861
crossref_primary_10_1016_j_pmedr_2022_101929
crossref_primary_10_1111_ajo_13684
crossref_primary_10_1371_journal_pone_0299651
crossref_primary_10_1016_j_jiph_2023_06_016
crossref_primary_10_1186_s12905_023_02538_2
Cites_doi 10.1002/ijc.31261
10.1016/j.pathol.2019.07.014
10.1016/S1470-2045(06)70731-8
10.3390/v9100267
10.1002/ijc.29143
10.1158/0008-5472.CAN-05-3066
10.1038/bjc.2011.351
10.1016/0002-9378(95)90279-1
10.1002/cjp2.110
10.1097/AOG.0000000000000669
10.1136/bmj.g130
10.1016/j.cmi.2019.09.006
10.2807/1560-7917.ES.2018.23.41.1700737
10.1001/jama.2018.10400
10.3310/hta23280
10.17061/phrp2921914
10.5694/mja2.50223
10.5858/arpa.LGT200570
10.1016/j.vaccine.2018.11.075
10.1007/978-3-319-11074-5
10.1016/j.jcv.2015.11.015
ContentType Journal Article
Copyright 2020 UICC
2020 UICC.
Copyright_xml – notice: 2020 UICC
– notice: 2020 UICC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
DOI 10.1002/ijc.33128
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 3074
ExternalDocumentID 32484236
10_1002_ijc_33128
IJC33128
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GrantInformation_xml – fundername: National Health and Medical Research Council
  funderid: 568971
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
.55
.GJ
.Y3
31~
3O-
53G
8WZ
A6W
AAMMB
AANHP
AAYXX
ABEFU
ABEML
ACBWZ
ACRPL
ACSCC
ACYXJ
ADNMO
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AHEFC
AI.
AIDQK
AIDYY
AIQQE
ASPBG
AVWKF
AZFZN
BDRZF
CITATION
EJD
EX3
FEDTE
GLUZI
HF~
HVGLF
LW6
M6P
PALCI
RJQFR
SAMSI
VH1
WOW
X7M
Y6R
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c2688-6dc83b1f599074c9f0f5eedcb010daed58edf8a4c5df31120a3bc570706a57bd3
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Fri Jul 11 12:43:06 EDT 2025
Tue Oct 07 06:23:57 EDT 2025
Thu Apr 03 06:59:13 EDT 2025
Wed Oct 01 03:10:22 EDT 2025
Thu Apr 24 23:12:47 EDT 2025
Wed Jan 22 16:32:26 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords positive predictive value
screening
cervical cancer
human papillomavirus
Language English
License 2020 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2688-6dc83b1f599074c9f0f5eedcb010daed58edf8a4c5df31120a3bc570706a57bd3
Notes Funding information
National Health and Medical Research Council, Grant/Award Number: 568971
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2358-4972
PMID 32484236
PQID 2449425235
PQPubID 105430
PageCount 7
ParticipantIDs proquest_miscellaneous_2408823232
proquest_journals_2449425235
pubmed_primary_32484236
crossref_primary_10_1002_ijc_33128
crossref_citationtrail_10_1002_ijc_33128
wiley_primary_10_1002_ijc_33128_IJC33128
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 1 December 2020
2020-12-00
2020-12-01
20201201
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: 1 December 2020
  day: 01
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2011; 105
2018; 320
2017; 8
2018; 143
2014; 348
2019; 51
2018; 4
2015; 125
2015; 136
2006; 66
2017 Sep 21
2019; 23
2019; 37
2006; 7
2016; 76
2019
2020; 26
2017
2019; 29
2015
2018; 23
2012; 136
1995; 173
2019; 211
e_1_2_9_20_1
e_1_2_9_11_1
e_1_2_9_22_1
e_1_2_9_10_1
e_1_2_9_21_1
e_1_2_9_13_1
e_1_2_9_24_1
e_1_2_9_12_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_3_1
e_1_2_9_2_1
Australian Institute for Health and Welfare (e_1_2_9_4_1) 2019
e_1_2_9_9_1
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_25_1
e_1_2_9_17_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
Koliopoulos G (e_1_2_9_5_1) 2017; 8
References_xml – volume: 66
  start-page: 1218
  year: 2006
  end-page: 1224
  article-title: Age‐related changes of the cervix influence human papillomavirus type distribution
  publication-title: Cancer Res
– volume: 4
  start-page: 207
  year: 2018
  end-page: 212
  article-title: The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality
  publication-title: J Pathol Clin Res
– volume: 143
  start-page: 735
  year: 2018
  end-page: 745
  article-title: Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs
  publication-title: Int J Cancer
– volume: 37
  start-page: 412
  year: 2019
  end-page: 416
  article-title: Age‐specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: a new tool for monitoring vaccine impact
  publication-title: Vaccine
– volume: 125
  start-page: 330
  year: 2015
  end-page: 337
  article-title: Use of primary high‐risk human papillomavirus testing for cervical cancer screening: interim clinical guidance
  publication-title: Obstet Gynecol
– volume: 320
  start-page: 687
  year: 2018
  end-page: 705
  article-title: Screening for cervical cancer with high‐risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force
  publication-title: JAMA
– volume: 7
  start-page: 547
  year: 2006
  end-page: 555
  article-title: Human papillomavirus testing and liquid‐based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
  publication-title: Lancet Oncol
– volume: 51
  start-page: 752
  year: 2019
  end-page: 755
  article-title: Histopathological evaluation of colposcopic biopsies, LLETZ and cold knife cone biopsies of the uterine cervix in post‐menopausal women: considerations in the setting of the new Australian cervical HPV DNA screening program
  publication-title: Pathology
– volume: 136
  start-page: 1266
  year: 2012
  end-page: 1297
  article-title: The lower Anogenital squamous terminology standardization project for HPV‐associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
  publication-title: Arch Pathol Lab Med
– volume: 29
  issue: 2
  year: 2019
  article-title: Lessons from the renewal of the National Cervical Screening Program in Australia
  publication-title: Public Health Res Pract
– volume: 348
  year: 2014
  article-title: Long term duration of protective effect for HPV negative women: follow‐up of primary HPV screening randomised controlled trial
  publication-title: BMJ
– volume: 136
  start-page: 1665
  year: 2015
  end-page: 1671
  article-title: Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection
  publication-title: Int J Cancer
– volume: 173
  start-page: 534
  year: 1995
  end-page: 543
  article-title: Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching
  publication-title: Am J Obstet Gynecol
– volume: 76
  start-page: S49
  issue: Suppl 1
  year: 2016
  end-page: S55
  article-title: Triage of HPV positive women in cervical cancer screening
  publication-title: J Clin Virol
– year: 2017
– volume: 211
  start-page: 113
  year: 2019
  end-page: 119
  article-title: Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program
  publication-title: Med J Aust
– volume: 26
  start-page: 579
  year: 2020
  end-page: 583
  article-title: Primary HPV‐based cervical cancer screening in Europe: implementation status, challenges, and future plans
  publication-title: Clin Microbiol Infect
– volume: 105
  start-page: 877
  year: 2011
  end-page: 880
  article-title: Use of HC2 to triage women with borderline and mild dyskaryosis in the UK
  publication-title: Br J Cancer
– year: 2019
– year: 2017 Sep 21
– year: 2015
– volume: 23
  year: 2018
  article-title: The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
  publication-title: Euro Surveill
– volume: 8
  year: 2017
  article-title: Cytology versus HPV testing for cervical cancer screening in the general population (review)
  publication-title: Cochrane Database Syst Rev
– volume: 23
  start-page: 1
  year: 2019
  end-page: 44
  article-title: HPV testing compared with routine cytology in cervical screening: long‐term follow‐up of ARTISTIC RCT
  publication-title: Health Technol Assess
– ident: e_1_2_9_2_1
– ident: e_1_2_9_17_1
  doi: 10.1002/ijc.31261
– ident: e_1_2_9_8_1
  doi: 10.1016/j.pathol.2019.07.014
– ident: e_1_2_9_13_1
  doi: 10.1016/S1470-2045(06)70731-8
– ident: e_1_2_9_23_1
  doi: 10.3390/v9100267
– ident: e_1_2_9_18_1
  doi: 10.1002/ijc.29143
– ident: e_1_2_9_21_1
  doi: 10.1158/0008-5472.CAN-05-3066
– ident: e_1_2_9_11_1
  doi: 10.1038/bjc.2011.351
– ident: e_1_2_9_22_1
  doi: 10.1016/0002-9378(95)90279-1
– volume: 8
  start-page: CD008587
  year: 2017
  ident: e_1_2_9_5_1
  article-title: Cytology versus HPV testing for cervical cancer screening in the general population (review)
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_9_25_1
  doi: 10.1002/cjp2.110
– volume-title: Cancer in Australia 2019 (Cat No. CAN 119; Cancer Series No. 123)
  year: 2019
  ident: e_1_2_9_4_1
– ident: e_1_2_9_14_1
  doi: 10.1097/AOG.0000000000000669
– ident: e_1_2_9_20_1
  doi: 10.1136/bmj.g130
– ident: e_1_2_9_15_1
  doi: 10.1016/j.cmi.2019.09.006
– ident: e_1_2_9_3_1
  doi: 10.2807/1560-7917.ES.2018.23.41.1700737
– ident: e_1_2_9_12_1
  doi: 10.1001/jama.2018.10400
– ident: e_1_2_9_19_1
  doi: 10.3310/hta23280
– ident: e_1_2_9_7_1
  doi: 10.17061/phrp2921914
– ident: e_1_2_9_6_1
  doi: 10.5694/mja2.50223
– ident: e_1_2_9_10_1
  doi: 10.5858/arpa.LGT200570
– ident: e_1_2_9_24_1
  doi: 10.1016/j.vaccine.2018.11.075
– ident: e_1_2_9_9_1
  doi: 10.1007/978-3-319-11074-5
– ident: e_1_2_9_16_1
  doi: 10.1016/j.jcv.2015.11.015
SSID ssj0011504
Score 2.4249067
Snippet Australia's new HPV‐based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow‐up with...
Australia's new HPV-based cervical screening program is based on an algorithm that incorporates reflex cytology to guide decisions about further follow-up with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3068
SubjectTerms Adult
Age
Age Factors
Aged
Algorithms
Biopsy
Cancer
Cellular biology
Cervical cancer
Cervical Intraepithelial Neoplasia - diagnosis
Cervical Intraepithelial Neoplasia - epidemiology
Cervical Intraepithelial Neoplasia - virology
Colposcopy
Colposcopy - methods
Cytology
Early Detection of Cancer
Female
human papillomavirus
Human papillomavirus 16 - isolation & purification
Human papillomavirus 18 - isolation & purification
Humans
Medical research
Medical screening
Middle Aged
Neoplasm Grading
Papillomavirus Infections - complications
Papillomavirus Infections - virology
positive predictive value
Referral and Consultation
screening
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - virology
Title Detection of high‐grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.33128
https://www.ncbi.nlm.nih.gov/pubmed/32484236
https://www.proquest.com/docview/2449425235
https://www.proquest.com/docview/2408823232
Volume 147
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0020-7136
  databaseCode: DR2
  dateStart: 19960101
  customDbUrl:
  isFulltext: true
  eissn: 1097-0215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011504
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LShxBFL2Ii5BNniaZqOEmZJFNjzNdXdXVuBITmQiGIDG4CDTV9RAT6ZaZHmFc-Ql-gt_ml3ir-iHGBELoTUNX0a_7OKce5wK8t4TYdGbIkVxso0QKHmWS_LFgNk1srDKZ-M3Je1_E5CDZPeSHS7DZ7YVp9CH6ATfvGSFeewdXxWzjVjT0-KceMkbhleLvmIlAp_Z76SgPdFoF5lFEREx0qkKjeKPveTcX3QOYd_FqSDg7j-FH96jNOpNfw3ldDPX5byqO__kuT-BRC0Rxq7Gcp7Bky2fwYK-dan8OVx9tHZZplVg59KrG1xeXR1NlLOoQX6hzO7uDoWIRBjEHDHVLptZgkyxPFlhXSNZ2WvkNMAsMRclRYbNa7Mzi5Ot3pNhFfJqyKBLyrfEsEHj0Y8RI8Q5VaVAvQqXdBYZZ9vJotgIHO5--bU-itpxDpGNB_iiMlqwYO555Qq4zN3KcMrQuiBIaZQ2X1jipEs2NYwQDR4oVmqcUk4TiaWHYC1guq9K-AtQJcYLUMSlEmlA_qVw2TjizY0uMXrgBfOh-bK5brXNfcuMkb1Sa45y-eB6--ADe9U1PG4GPPzVa66wjb318lhMwyijixYwP4G1_mbzTT7mo0lZz38ZTGEbHAF42VtXfhaCsJDAr6GGDbfz99vnn3e1w8vrfm67Cw9jbflh5swbL9XRu1wk_1cWb4Cg3mQgYsw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtRAEC0lQSJcWBMYCFAgDlw8mXG7222JCwpEk5CJEEpQLshq9xIBkR1NPJGGE5_AJ_BtfAnV7QWFRYqQL5bcLW_1ql718grgmSXGpjNDQHKxjRIpeJRJwmPBbJrYWGUy8ZuTp_ticpjsHvGjJXjR7YVp9CH6ATePjOCvPcD9gPTmL9XQj5_0kDHyr8twJRGUp3hK9K4Xj_JUp9VgHkWUiolOV2gUb_ZdL0ajPyjmRcYaQs72DfjQPWyz0uTzcF4XQ_3lNx3H_32bm3C95aL4sjGeW7Bky9twddrOtt-B769sHVZqlVg59MLGP75-O54pY1EHF0Od2wkeDEWLMOg5YChdMrMGm3h5ssC6QjK408rvgVlgqEuOCpsFY-cWJ2_fI7kvSqkpkCKR3xrPQw6PfpgYyeWhKg3qRSi2u8Aw0V4en63B4fbrg61J1FZ0iHQsCJLCaMmKseOZz8l15kaOU5DWBWWFRlnDpTVOqkRz4xgxwZFiheYpuSWheFoYtg4rZVXae4A6obQgdUwKkSbUTyqXjRPO7NhSUi_cAJ53fzbXrdy5r7pxkjdCzXFOXzwPX3wAT_ump43Gx98abXTmkbcwP8uJG2Xk9GLGB_Ckv0wA9bMuqrTV3LfxWQyjYwB3G7Pq70JsVhKfFfSwwTj-fft8Z3crnNy_fNPHsDo5mO7lezv7bx7AtdgDISzE2YCVeja3D4lO1cWjgJqfGFEc1A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bahRBEC1ihOCLd-Nq1FJ88GU2u9PTPT3gi2RdNtGEIEbyIkNPX4IaZpbNbGB98hP8BL_NL7G65yLxAiL7MrDdzK1O1anp6lMATy0xNp0ZApKLbZRIwaNMEh4LZtPExiqTid-cvH8gZkfJ3jE_XoPn3V6YRh-i_-DmkRH8tQe4nRu3_VM19MNHPWSM_OsluJzwTPqCvsmbXjzKU51Wg3kUUSomOl2hUbzdT70YjX6jmBcZawg502vwvrvYptLk03BZF0P9-Rcdx_-9m-twteWi-KIxnhuwZsubsLHfrrbfgm8TW4dKrRIrh17Y-PuXrycLZSzq4GJocrvAg6FpEQY9BwytSxbWYBMvT1dYV0gGN6_8HpgVhr7kqLApGDu3ODt8h-S-KKWmQIpEfms8Dzk8-s_ESC4PVWlQr0Kz3RWGhfby5Ow2HE1fvt2ZRW1Hh0jHgiApjJasGDue-ZxcZ27kOAVpXVBWaJQ1XFrjpEo0N44RExwpVmieklsSiqeFYXdgvaxKexdQJ5QWpI5JIdKE5knlsnHCmR1bSuqFG8Cz7s3mupU79103TvNGqDnO6Ynn4YkP4Ek_dN5ofPxp0FZnHnkL87OcuFFGTi9mfACP-78JoH7VRZW2WvoxPoth9BvAZmNW_VmIzUris4IuNhjH30-f7-7thIN7_z70EWwcTqb5692DV_fhSuxxEOpwtmC9XiztA2JTdfEwgOYHmfQcWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+high%E2%80%90grade+cervical+disease+among+women+referred+directly+to+colposcopy+after+a+positive+HPV+screening+test+varies+with+age+and+cytology+findings&rft.jtitle=International+journal+of+cancer&rft.au=Farnsworth%2C+Annabelle&rft.au=Roberts%2C+Jennifer+M.&rft.au=Garland%2C+Suzanne+M.&rft.au=Crescini%2C+Joanne&rft.date=2020-12-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=147&rft.issue=11&rft.spage=3068&rft.epage=3074&rft_id=info:doi/10.1002%2Fijc.33128&rft.externalDBID=10.1002%252Fijc.33128&rft.externalDocID=IJC33128
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon